GSK3B and ovarian carcinoma: Loss of AKT phosphorylation at S473 in mitotically arrested ovarian cancer cells was accompanied by a significant decrease in AKT activity, since the phosphorylation of several downstream targets of AKT, such as GSK3β, PRAS40 and p70S6K, was reduced (Figure 1C).